Home › Compare › ZMDTF vs MRK

ZMDTF vs MRK: Dividend Comparison 2026

ZMDTF yields 322.58% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZMDTF wins by $2480.61M in total portfolio value
10 years
ZMDTF
ZMDTF
● Live price
322.58%
Share price
$0.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2480.67M
Annual income
$1,540,963,923.92
Full ZMDTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ZMDTF vs MRK

📍 ZMDTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZMDTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZMDTF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ZMDTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZMDTF
Annual income on $10K today (after 15% tax)
$27,419.35/yr
After 10yr DRIP, annual income (after tax)
$1,309,819,335.33/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ZMDTF beats the other by $1,309,811,006.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZMDTF + MRK for your $10,000?

ZMDTF: 50%MRK: 50%
100% MRK50/50100% ZMDTF
Portfolio after 10yr
$1240.36M
Annual income
$770,486,861.03/yr
Blended yield
62.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZMDTF
No analyst data
Altman Z
7.6
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZMDTF buys
0
MRK buys
0
No recent congressional trades found for ZMDTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZMDTFMRK
Forward yield322.58% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$2480.67M ✓$56.8K
Annual income after 10y$1,540,963,923.92 ✓$9,798.13
Total dividends collected$2388.58M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZMDTF vs MRK ($10,000, DRIP)

YearZMDTF PortfolioZMDTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$42,958$32,258.06$11,206$366.19+$31.8K → ZMDTF
2$175,474$129,508.79$12,650$502.35+$162.8K → ZMDTF
3$682,163$494,405.53$14,407$694.19+$667.8K → ZMDTF
4$2,526,198$1,796,283.54$16,585$967.82+$2.51M → ZMDTF
5$8,919,883$6,216,851.64$19,342$1,363.89+$8.90M → ZMDTF
6$30,059,608$20,515,333.23$22,913$1,947.19+$30.04M → ZMDTF
7$96,776,639$64,612,858.30$27,662$2,823.89+$96.75M → ZMDTF
8$297,962,703$194,411,699.68$34,159$4,173.35+$297.93M → ZMDTF
9$878,229,790$559,409,697.26$43,337$6,308.80+$878.19M → ZMDTF
10$2,480,669,799$1,540,963,923.92$56,776$9,798.13+$2480.61M → ZMDTF

ZMDTF vs MRK: Complete Analysis 2026

ZMDTF — Stock

Zoomd Technologies Ltd. develops proprietary patented technology for leveraging onsite search for publishers, media agencies, and advertisers. It offers an internal site search engine for clients to implement search in publishers' web site. The company also provides unified mobile user acquisition platform for managing various user acquisition activity under one unified command and control screen. In addition, it offers App marketing, SaaS mobile, mobile demand side platform, UA managed, creator generated content, Website publisher, site search engine, and Web monetization services. The company was founded in 2012 and is based in Vancouver, Canada.

Full ZMDTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ZMDTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZMDTF vs SCHDZMDTF vs JEPIZMDTF vs OZMDTF vs KOZMDTF vs MAINZMDTF vs JNJZMDTF vs ABBVZMDTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.